Valuation: Evotec SE

Capitalization 1.53B 1.61B 1.42B 1.26B 2.27B 136B 2.52B 17.66B 6.54B 56.04B 6.04B 5.9B 245B P/E ratio 2024 *
-11x
P/E ratio 2025 * -39x
Enterprise value 1.66B 1.74B 1.54B 1.37B 2.46B 148B 2.74B 19.14B 7.09B 60.74B 6.54B 6.4B 266B EV / Sales 2024 *
2.06x
EV / Sales 2025 * 1.91x
Free-Float
-
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.87%
1 week-0.63%
Current month-2.10%
1 month-3.03%
3 months+42.66%
6 months-2.54%
Current year-59.38%
More quotes
1 week
8.65
Extreme 8.645
9.12
1 month
7.98
Extreme 7.98
10.62
Current year
5.06
Extreme 5.06
21.42
1 year
5.06
Extreme 5.06
21.69
3 years
5.06
Extreme 5.06
44.94
5 years
5.06
Extreme 5.06
45.83
10 years
2.86
Extreme 2.864
45.83
More quotes
Director TitleAgeSince
Chief Executive Officer - 30/06/2024
Director of Finance/CFO 51 31/03/2023
Chief Operating Officer 54 31/12/2018
Manager TitleAgeSince
Chairman 64 14/06/2021
Director/Board Member 56 18/06/2019
Director/Board Member 62 31/05/2021
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.87%-0.63%-53.14%-79.00%1.64B
-0.15%-1.14%+60.74%-30.59%42.84B
-1.05%-1.03%-7.05%-25.62%36.88B
+1.15%+0.66%+3.66%-6.06%26.23B
-1.75%-1.08%-22.76%-23.43%17.83B
-0.02%-3.27%+47.90%+92.06%16.17B
+3.25%+2.95%-47.73%-83.33%15.97B
-0.40%+1.21%+11.32%-34.07%12.25B
-0.13%-1.39%+21.16%+66.86%10.6B
+0.20%+5.46%+6.41%-17.62%10.24B
Average -0.08%+0.07%+2.05%-14.08% 19.07B
Weighted average by Cap. -0.01%-0.10%+12.51%-14.12%
See all sector performances

Financials

2024 *2025 *
Net sales 805M 844M 746M 662M 1.19B 71.55B 1.33B 9.27B 3.43B 29.42B 3.17B 3.1B 129B 902M 946M 836M 742M 1.34B 80.2B 1.49B 10.39B 3.85B 32.98B 3.55B 3.47B 144B
Net income -144M -151M -134M -118M -214M -12.81B -237M -1.66B -614M -5.27B -567M -555M -23.03B -38.05M -39.89M -35.28M -31.29M -56.41M -3.38B -62.66M -438M -162M -1.39B -150M -147M -6.08B
Net Debt 129M 135M 119M 106M 191M 11.43B 212M 1.48B 548M 4.7B 506M 495M 20.56B 193M 202M 179M 158M 286M 17.13B 317M 2.22B 822M 7.04B 759M 742M 30.81B
More financial data * Estimated data
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
5,007
More about the company
Date Price Change Volume
11/12/24 8.645 -1.87% 773,182
10/12/24 8.810 -0.45% 1,555,984
09/12/24 8.850 +0.91% 788,299
06/12/24 8.770 -1.79% 587,050
05/12/24 8.930 +2.64% 766,088

Delayed Quote Xetra, December 11, 2024 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart EVOTEC-SEMore Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.645EUR
Average target price
11.04EUR
Spread / Average Target
+27.67%
Consensus

Quarterly revenue - Rate of surprise